Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Macrophages | 14 | 2017 | 183 | 2.040 |
Why?
|
Monocytes | 7 | 2021 | 119 | 1.850 |
Why?
|
Cholesterol | 12 | 2020 | 231 | 1.840 |
Why?
|
Inflammation | 9 | 2022 | 501 | 1.540 |
Why?
|
Fatty Acids, Omega-3 | 4 | 2020 | 52 | 1.460 |
Why?
|
ATP-Binding Cassette Transporters | 6 | 2013 | 60 | 1.370 |
Why?
|
Energy Metabolism | 2 | 2020 | 139 | 1.310 |
Why?
|
Signal Transduction | 7 | 2020 | 607 | 1.080 |
Why?
|
Atherosclerosis | 9 | 2020 | 725 | 1.070 |
Why?
|
Mice | 29 | 2022 | 2181 | 1.000 |
Why?
|
Lipoproteins, HDL | 7 | 2015 | 269 | 0.900 |
Why?
|
Animals | 33 | 2022 | 6402 | 0.860 |
Why?
|
Membrane Microdomains | 5 | 2015 | 24 | 0.810 |
Why?
|
Pyruvate Dehydrogenase Complex | 2 | 2022 | 13 | 0.790 |
Why?
|
Succinates | 1 | 2020 | 4 | 0.750 |
Why?
|
Citric Acid Cycle | 1 | 2020 | 6 | 0.740 |
Why?
|
Liver | 7 | 2017 | 466 | 0.720 |
Why?
|
Apolipoprotein A-I | 7 | 2015 | 68 | 0.710 |
Why?
|
Mice, Inbred C57BL | 13 | 2017 | 619 | 0.670 |
Why?
|
Fatty Acids, Omega-6 | 2 | 2017 | 30 | 0.660 |
Why?
|
Toll-Like Receptors | 3 | 2015 | 21 | 0.650 |
Why?
|
Autophagy | 2 | 2017 | 53 | 0.640 |
Why?
|
Dietary Fats | 2 | 2017 | 107 | 0.610 |
Why?
|
Mice, Knockout | 12 | 2020 | 392 | 0.590 |
Why?
|
Receptors, LDL | 9 | 2020 | 64 | 0.580 |
Why?
|
Aging | 3 | 2020 | 857 | 0.580 |
Why?
|
Myeloid Differentiation Factor 88 | 3 | 2010 | 16 | 0.560 |
Why?
|
Lipopolysaccharides | 7 | 2020 | 104 | 0.560 |
Why?
|
Myeloid Cells | 2 | 2014 | 35 | 0.560 |
Why?
|
Insulin Resistance | 4 | 2017 | 494 | 0.480 |
Why?
|
Listeria monocytogenes | 1 | 2012 | 8 | 0.450 |
Why?
|
Apolipoproteins | 5 | 2015 | 217 | 0.440 |
Why?
|
Hematopoiesis | 1 | 2012 | 34 | 0.430 |
Why?
|
Lipid Metabolism | 4 | 2019 | 102 | 0.410 |
Why?
|
Hepatocytes | 3 | 2017 | 74 | 0.390 |
Why?
|
Carnitine | 2 | 2020 | 11 | 0.360 |
Why?
|
Mitochondria | 3 | 2022 | 175 | 0.360 |
Why?
|
Principal Component Analysis | 2 | 2020 | 60 | 0.360 |
Why?
|
Amino Acids | 2 | 2020 | 35 | 0.350 |
Why?
|
Metabolome | 2 | 2020 | 32 | 0.350 |
Why?
|
Cytokines | 5 | 2020 | 239 | 0.350 |
Why?
|
Obesity | 3 | 2013 | 1079 | 0.340 |
Why?
|
Cysteine | 2 | 2008 | 129 | 0.320 |
Why?
|
Apolipoproteins E | 4 | 2013 | 101 | 0.260 |
Why?
|
Sphingosine | 2 | 2015 | 14 | 0.250 |
Why?
|
Lysophospholipids | 2 | 2015 | 26 | 0.250 |
Why?
|
Cells, Cultured | 5 | 2015 | 779 | 0.250 |
Why?
|
Cardiovascular Diseases | 1 | 2012 | 1059 | 0.250 |
Why?
|
Humans | 17 | 2022 | 28304 | 0.240 |
Why?
|
Plant Oils | 2 | 2015 | 14 | 0.240 |
Why?
|
Macrophages, Peritoneal | 2 | 2014 | 19 | 0.240 |
Why?
|
Interleukin-1beta | 3 | 2020 | 40 | 0.240 |
Why?
|
Sepsis | 2 | 2022 | 145 | 0.240 |
Why?
|
Fatty Acids | 3 | 2020 | 93 | 0.230 |
Why?
|
Chemokines | 2 | 2013 | 34 | 0.230 |
Why?
|
Eicosapentaenoic Acid | 1 | 2022 | 27 | 0.220 |
Why?
|
Pyruvic Acid | 1 | 2022 | 5 | 0.220 |
Why?
|
Aortic Diseases | 2 | 2013 | 56 | 0.220 |
Why?
|
Male | 12 | 2020 | 16967 | 0.210 |
Why?
|
Endothelium, Vascular | 3 | 2012 | 149 | 0.200 |
Why?
|
Oxidation-Reduction | 2 | 2020 | 251 | 0.200 |
Why?
|
NF-kappa B | 3 | 2010 | 76 | 0.200 |
Why?
|
Enzyme Activation | 3 | 2017 | 120 | 0.200 |
Why?
|
Glycolysis | 1 | 2020 | 19 | 0.190 |
Why?
|
Oxidative Phosphorylation | 1 | 2020 | 22 | 0.190 |
Why?
|
Gene Deletion | 4 | 2017 | 64 | 0.190 |
Why?
|
Lipids | 2 | 2020 | 215 | 0.190 |
Why?
|
Diet, Atherogenic | 3 | 2015 | 61 | 0.190 |
Why?
|
Ketones | 1 | 2020 | 7 | 0.190 |
Why?
|
Endothelial Cells | 1 | 2021 | 176 | 0.190 |
Why?
|
Disease Models, Animal | 3 | 2020 | 915 | 0.190 |
Why?
|
Caspase 1 | 2 | 2017 | 6 | 0.180 |
Why?
|
NAD | 1 | 2019 | 24 | 0.180 |
Why?
|
Transcription Factor RelB | 1 | 2019 | 25 | 0.180 |
Why?
|
Sirtuin 1 | 1 | 2019 | 36 | 0.180 |
Why?
|
Stearoyl-CoA Desaturase | 2 | 2009 | 15 | 0.180 |
Why?
|
Immune Tolerance | 1 | 2019 | 67 | 0.180 |
Why?
|
Carbohydrate Metabolism | 1 | 2019 | 12 | 0.170 |
Why?
|
Nucleotides | 1 | 2019 | 16 | 0.170 |
Why?
|
Aorta | 3 | 2015 | 105 | 0.170 |
Why?
|
Antioxidants | 2 | 2010 | 117 | 0.150 |
Why?
|
Lipogenesis | 1 | 2017 | 18 | 0.150 |
Why?
|
Algorithms | 1 | 2020 | 456 | 0.150 |
Why?
|
Mice, Transgenic | 2 | 2013 | 221 | 0.140 |
Why?
|
Toll-Like Receptor 4 | 3 | 2010 | 41 | 0.140 |
Why?
|
Inflammation Mediators | 2 | 2013 | 101 | 0.140 |
Why?
|
Orphan Nuclear Receptors | 1 | 2015 | 8 | 0.140 |
Why?
|
Female | 7 | 2020 | 17679 | 0.140 |
Why?
|
Scavenger Receptors, Class B | 1 | 2015 | 13 | 0.130 |
Why?
|
Cholesterol Esters | 1 | 2015 | 37 | 0.130 |
Why?
|
Spleen | 2 | 2013 | 82 | 0.130 |
Why?
|
Cell Membrane | 1 | 2015 | 79 | 0.130 |
Why?
|
Hypertension | 1 | 2022 | 978 | 0.130 |
Why?
|
Protein Sorting Signals | 1 | 2015 | 5 | 0.130 |
Why?
|
Glycoproteins | 1 | 2015 | 35 | 0.130 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2015 | 59 | 0.130 |
Why?
|
Fatty Acid Desaturases | 1 | 2015 | 45 | 0.130 |
Why?
|
Nerve Tissue Proteins | 1 | 2015 | 95 | 0.130 |
Why?
|
Mitochondrial Proteins | 1 | 2015 | 68 | 0.130 |
Why?
|
Proteomics | 1 | 2015 | 86 | 0.130 |
Why?
|
Fish Oils | 2 | 2015 | 34 | 0.120 |
Why?
|
Lipocalins | 1 | 2013 | 5 | 0.120 |
Why?
|
Adipose Tissue, White | 1 | 2013 | 6 | 0.120 |
Why?
|
Mice, Obese | 1 | 2013 | 20 | 0.120 |
Why?
|
Epididymis | 1 | 2013 | 9 | 0.120 |
Why?
|
Apoptosis | 2 | 2012 | 333 | 0.120 |
Why?
|
Liver Neoplasms | 1 | 2015 | 161 | 0.120 |
Why?
|
Genetic Variation | 1 | 2015 | 278 | 0.120 |
Why?
|
Membrane Proteins | 1 | 2015 | 260 | 0.120 |
Why?
|
Vasculitis | 1 | 2013 | 23 | 0.120 |
Why?
|
Macrophage Inflammatory Proteins | 2 | 2003 | 3 | 0.110 |
Why?
|
Diamide | 2 | 2003 | 3 | 0.110 |
Why?
|
Lipoproteins | 1 | 2013 | 82 | 0.110 |
Why?
|
Chemotaxis | 1 | 2012 | 22 | 0.110 |
Why?
|
Host-Pathogen Interactions | 1 | 2012 | 30 | 0.110 |
Why?
|
Thymus Gland | 1 | 2012 | 15 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 236 | 0.110 |
Why?
|
Lymphocytes | 1 | 2012 | 52 | 0.110 |
Why?
|
Recombinant Proteins | 3 | 2010 | 240 | 0.110 |
Why?
|
Bone Marrow Cells | 1 | 2012 | 116 | 0.110 |
Why?
|
Blotting, Western | 1 | 2012 | 265 | 0.100 |
Why?
|
Hematopoietic Stem Cells | 1 | 2012 | 96 | 0.100 |
Why?
|
Carrier Proteins | 1 | 2012 | 116 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 938 | 0.100 |
Why?
|
Apolipoproteins A | 2 | 2008 | 25 | 0.100 |
Why?
|
Dietary Supplements | 1 | 2012 | 171 | 0.100 |
Why?
|
Toll-Like Receptor 9 | 1 | 2010 | 6 | 0.100 |
Why?
|
Protein Transport | 1 | 2010 | 64 | 0.100 |
Why?
|
Cholesterol, VLDL | 3 | 2015 | 11 | 0.100 |
Why?
|
Oligoribonucleotides, Antisense | 1 | 2009 | 2 | 0.090 |
Why?
|
Mutation | 3 | 2010 | 451 | 0.090 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2009 | 26 | 0.090 |
Why?
|
Cell Proliferation | 1 | 2012 | 567 | 0.090 |
Why?
|
Carotid Artery Diseases | 1 | 2010 | 114 | 0.090 |
Why?
|
Time Factors | 3 | 2013 | 1874 | 0.090 |
Why?
|
Circular Dichroism | 2 | 2006 | 28 | 0.090 |
Why?
|
beta-Cyclodextrins | 1 | 2008 | 4 | 0.080 |
Why?
|
Endotoxemia | 1 | 2008 | 8 | 0.080 |
Why?
|
Kinetics | 2 | 2006 | 185 | 0.080 |
Why?
|
Kringles | 1 | 2008 | 1 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2008 | 59 | 0.080 |
Why?
|
Lipid Peroxidation | 2 | 2005 | 36 | 0.080 |
Why?
|
Neoplasms, Experimental | 1 | 2008 | 27 | 0.080 |
Why?
|
Biological Transport | 3 | 2013 | 57 | 0.080 |
Why?
|
Angiogenesis Inhibitors | 1 | 2008 | 33 | 0.080 |
Why?
|
Neovascularization, Pathologic | 1 | 2008 | 82 | 0.080 |
Why?
|
Lipoproteins, LDL | 2 | 2021 | 77 | 0.070 |
Why?
|
Lipoprotein Lipase | 1 | 2006 | 14 | 0.070 |
Why?
|
Models, Biological | 1 | 2008 | 356 | 0.070 |
Why?
|
Rats | 2 | 2022 | 1425 | 0.070 |
Why?
|
Lipoxygenase | 1 | 2005 | 1 | 0.070 |
Why?
|
Dimyristoylphosphatidylcholine | 1 | 2005 | 5 | 0.070 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 35 | 0.070 |
Why?
|
Gene Expression | 2 | 2006 | 324 | 0.070 |
Why?
|
Thermodynamics | 1 | 2005 | 42 | 0.070 |
Why?
|
Protein Structure, Secondary | 1 | 2005 | 41 | 0.070 |
Why?
|
Structure-Activity Relationship | 1 | 2005 | 73 | 0.070 |
Why?
|
Plasmids | 1 | 2005 | 48 | 0.070 |
Why?
|
Peptides | 1 | 2005 | 116 | 0.060 |
Why?
|
Echium | 2 | 2015 | 10 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2005 | 436 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2019 | 203 | 0.060 |
Why?
|
Bone Marrow Transplantation | 2 | 2014 | 65 | 0.060 |
Why?
|
Cholesterol, LDL | 2 | 2014 | 165 | 0.060 |
Why?
|
Antineoplastic Agents | 1 | 2008 | 532 | 0.060 |
Why?
|
Hypertrophy | 1 | 2022 | 24 | 0.060 |
Why?
|
Rats, Inbred SHR | 1 | 2022 | 61 | 0.060 |
Why?
|
Cholesterol, Dietary | 2 | 2013 | 37 | 0.060 |
Why?
|
Interleukin-10 | 1 | 2022 | 30 | 0.060 |
Why?
|
Acetates | 1 | 2022 | 15 | 0.060 |
Why?
|
Immunity, Innate | 2 | 2015 | 64 | 0.060 |
Why?
|
Ceramides | 2 | 2012 | 9 | 0.050 |
Why?
|
Fibrosis | 1 | 2022 | 112 | 0.050 |
Why?
|
Neutrophils | 2 | 2013 | 102 | 0.050 |
Why?
|
Fatty Liver | 2 | 2015 | 70 | 0.050 |
Why?
|
Anti-Inflammatory Agents | 1 | 2022 | 89 | 0.050 |
Why?
|
Carbon | 1 | 2021 | 9 | 0.050 |
Why?
|
Myocardium | 1 | 2022 | 197 | 0.050 |
Why?
|
Reactive Oxygen Species | 1 | 2021 | 164 | 0.050 |
Why?
|
Cell Wall | 1 | 2019 | 5 | 0.050 |
Why?
|
Teichoic Acids | 1 | 2019 | 7 | 0.050 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 2 | 0.050 |
Why?
|
Cell Line, Tumor | 2 | 2015 | 659 | 0.050 |
Why?
|
Nicotinamide Phosphoribosyltransferase | 1 | 2019 | 12 | 0.050 |
Why?
|
Caenorhabditis elegans | 1 | 2019 | 19 | 0.050 |
Why?
|
Protein Conformation | 2 | 2012 | 75 | 0.050 |
Why?
|
Hot Temperature | 1 | 2019 | 62 | 0.050 |
Why?
|
Endotoxins | 1 | 2019 | 36 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2019 | 147 | 0.040 |
Why?
|
Interleukin-6 | 2 | 2010 | 224 | 0.040 |
Why?
|
Cognition | 1 | 2019 | 512 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2015 | 21 | 0.030 |
Why?
|
Biological Transport, Active | 1 | 2015 | 8 | 0.030 |
Why?
|
Cricetulus | 1 | 2015 | 12 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2015 | 18 | 0.030 |
Why?
|
CHO Cells | 1 | 2015 | 22 | 0.030 |
Why?
|
gamma-Linolenic Acid | 1 | 2015 | 7 | 0.030 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2015 | 22 | 0.030 |
Why?
|
Ligands | 1 | 2015 | 59 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 73 | 0.030 |
Why?
|
Gene Silencing | 1 | 2015 | 50 | 0.030 |
Why?
|
Proteome | 1 | 2015 | 30 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 2015 | 268 | 0.030 |
Why?
|
Antigens, CD | 1 | 2015 | 101 | 0.030 |
Why?
|
Molecular Sequence Data | 1 | 2015 | 340 | 0.030 |
Why?
|
Mice, Inbred DBA | 1 | 2013 | 21 | 0.030 |
Why?
|
Particle Size | 1 | 2013 | 41 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2015 | 247 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 323 | 0.030 |
Why?
|
Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 2013 | 38 | 0.030 |
Why?
|
Bile | 1 | 2013 | 6 | 0.030 |
Why?
|
Feces | 1 | 2013 | 29 | 0.030 |
Why?
|
Animal Feed | 1 | 2013 | 14 | 0.030 |
Why?
|
Foam Cells | 1 | 2013 | 11 | 0.030 |
Why?
|
Apolipoproteins B | 1 | 2013 | 44 | 0.030 |
Why?
|
Triglycerides | 1 | 2014 | 220 | 0.030 |
Why?
|
Chemokine CCL4 | 2 | 2003 | 4 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2013 | 170 | 0.030 |
Why?
|
Antigens, Ly | 1 | 2012 | 6 | 0.030 |
Why?
|
Sphingomyelins | 1 | 2012 | 7 | 0.030 |
Why?
|
Cell Line | 1 | 2013 | 418 | 0.030 |
Why?
|
Interleukin-18 | 1 | 2012 | 8 | 0.030 |
Why?
|
Genotype | 1 | 2014 | 813 | 0.030 |
Why?
|
Organ Size | 1 | 2012 | 204 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2012 | 83 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2012 | 114 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2003 | 498 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2012 | 139 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2010 | 56 | 0.020 |
Why?
|
Toll-Like Receptor 2 | 1 | 2010 | 13 | 0.020 |
Why?
|
Apolipoprotein B-100 | 1 | 2009 | 11 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 44 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2009 | 52 | 0.020 |
Why?
|
Stem Cells | 1 | 2012 | 292 | 0.020 |
Why?
|
Oligonucleotides, Antisense | 1 | 2008 | 30 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2008 | 40 | 0.020 |
Why?
|
Chick Embryo | 1 | 2008 | 61 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2009 | 498 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2008 | 71 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2010 | 430 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2008 | 120 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2008 | 88 | 0.020 |
Why?
|
Mice, Nude | 1 | 2008 | 271 | 0.020 |
Why?
|
Lung | 1 | 2008 | 232 | 0.020 |
Why?
|
Cattle | 1 | 2006 | 97 | 0.020 |
Why?
|
Protein Binding | 1 | 2006 | 182 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2008 | 206 | 0.020 |
Why?
|
Chemokine CCL3 | 1 | 2003 | 5 | 0.010 |
Why?
|
Sulfhydryl Reagents | 1 | 2003 | 5 | 0.010 |
Why?
|
Umbilical Veins | 1 | 2003 | 12 | 0.010 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2003 | 18 | 0.010 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2002 | 15 | 0.010 |
Why?
|
Arteriosclerosis | 1 | 2002 | 126 | 0.010 |
Why?
|